HSBC HOLDINGS PLC

Position in TLRY — Tilray Brands, Inc.

CIK 873630 LONDON, X0

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$180,646

+$36,992 QoQ

Shares Held

40,233

+653.4% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 235 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $318,191,174 across 30 Drug Manufacturers - Specialty & Generic names. TLRY ranks #25 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,839,811	$132,208,811
2	UTHR	UNITED THERAPEUTICS Corp	127,125	$68,880,136
3	TEVA	Teva Pharmaceutical Industries Ltd	785,524	$26,613,551
4	VTRS	Viatris Inc	1,518,578	$24,115,016
5	HIMS	Hims & Hers Health, Inc.	632,408	$21,925,584
6	NBIX	Neurocrine Biosciences Inc	115,990	$19,548,952
7	LQDA	Liquidia Corp	117,620	$9,377,842
8	LNTH	Lantheus Holdings, Inc.	20,539	$2,278,595

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$180,646	40,233	-24.7%	Shares	Defined	2026-08-14
2022-12-31	$143,654	53,403	0.0%	Shares	Defined	2023-02-14
2022-09-30	$146,858	53,403	-35.9%	Shares	Defined	2022-11-14
2022-06-30	$259,758	83,256	-17.6%	Shares	Defined	2022-08-11
2022-03-31	$784,940	101,022	-10.8%	Shares	Defined	2022-05-16
2021-12-31	$795,760	113,195	+6.0%	Shares	Defined	2022-02-11
2021-09-30	$1,205,342	106,762	+9.6%	Shares	Defined	2021-11-12
2021-06-30	$1,761,299	97,417	+51.9%	Shares	Defined	2021-08-13
2021-03-31	$1,457,470	64,121	+37.2%	Shares	Defined	2021-05-14
2020-12-31	$386,121	46,746	+112.0%	Shares	Defined	2021-02-25
2020-09-30	$106,942	22,050	+53.9%	Shares	Defined	2020-11-12
2020-06-30	$101,843	14,324	+18.7%	Shares	Defined	2020-08-14
2020-03-31	$83,020	12,067	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.